| - GRCh37:
- Chr2:215590369-215632205
| BARD1 | | Malignant tumor of breast | Pathogenic (Aug 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:108121694-108121712
- GRCh38:
- Chr11:108250967-108250985
| ATM | Q501fs | Malignant tumor of breast | Pathogenic (Aug 21, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:108121642-108121643
- GRCh38:
- Chr11:108250915-108250916
| ATM | W484fs | Malignant tumor of breast | Pathogenic (Jul 14, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:68771367-68835572
| CDH1 | | Malignant tumor of breast | Pathogenic (Jul 13, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr10:89653830
- GRCh38:
- Chr10:87894073
| PTEN | E216G, E43G | Malignant tumor of breast | Uncertain significance (Jun 15, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7577095-7577096
- GRCh38:
- Chr17:7673777-7673778
| TP53 | D122fs, D149fs, D242fs, D281fs | Malignant tumor of breast | Pathogenic (May 31, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:23635326-23635332
- GRCh38:
- Chr16:23624005-23624011
| PALB2 | | Malignant tumor of breast | Likely pathogenic (Mar 30, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:108141861-108141882
- GRCh38:
- Chr11:108271134-108271155
| ATM | | Malignant tumor of breast | Likely pathogenic (Feb 21, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:131915658
- GRCh38:
- Chr5:132579966
| RAD50 | K219R | Hereditary cancer-predisposing syndrome, Malignant tumor of breast | Uncertain significance (May 30, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:108124733
- GRCh38:
- Chr11:108254006
| ATM | L697fs | Familial cancer of breast, Malignant tumor of breast | Pathogenic/Likely pathogenic (Jun 27, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:84383746
- GRCh38:
- Chr4:83462593
| ABRAXAS1 | R260Q, R369Q | Malignant tumor of breast, not provided, Hereditary cancer-predisposing syndrome
| Uncertain significance (Aug 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:59793317
- GRCh38:
- Chr17:61715956
| BRIP1 | G830fs | Malignant tumor of breast | Likely pathogenic (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:23614482-23625324
| PALB2 | | Malignant tumor of breast | Pathogenic (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:23614482-23619184
| PALB2 | | Malignant tumor of breast | Likely pathogenic (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:23635363-23637556
| PALB2 | | Malignant tumor of breast | Likely pathogenic (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:108115697
- GRCh38:
- Chr11:108244970
| ATM | L282* | Malignant tumor of breast | Likely pathogenic (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:108168110-108180886
| ATM | | Malignant tumor of breast | Pathogenic (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:88911696
- Chr11:89017961
- GRCh38:
- Chr11:89178528
- Chr11:89284793
| TYR, TYR | S192Y, R402Q | Tyrosinase-negative oculocutaneous albinism, Oculocutaneous albinism type 1B | Likely pathogenic (Feb 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:59934593-59940644
| BRIP1 | | Malignant tumor of breast | Likely pathogenic (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:108225602-108239827
| ATM | | Malignant tumor of breast | Pathogenic (Aug 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:23619334-23632682
| PALB2 | | Malignant tumor of breast | Pathogenic (Aug 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:23614482-23640524
| PALB2 | | Malignant tumor of breast | Pathogenic (Jul 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:108235811-108239828
| ATM | | Ataxia-telangiectasia syndrome, Malignant tumor of breast | not provided | no assertion provided |
| - GRCh37:
- Chr13:32911784
- GRCh38:
- Chr13:32337647
| BRCA2 | N1098Y | Hereditary cancer-predisposing syndrome | Likely benign (Mar 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:23614812-23614818
- GRCh38:
- Chr16:23603491-23603497
| PALB2 | Q1175fs | Malignant tumor of breast | Likely pathogenic (Jun 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:41244322-41244323
- GRCh38:
- Chr17:43092305-43092306
| LOC126862571, BRCA1 | N1028fs, N1075fs, N1074fs, N907fs, N963fs, N986fs, N987fs, N1005fs, N1007fs, N1008fs, N1033fs, N1049fs, N948fs, N964fs, N1027fs, N1004fs, N1034fs, N1048fs, N1072fs, N779fs, N947fs | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr8:90967644
- GRCh38:
- Chr8:89955416
| NBN | A340S, A422S | Microcephaly, normal intelligence and immunodeficiency | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:108115600
- GRCh38:
- Chr11:108244873
| ATM | | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr13:32931987
- GRCh38:
- Chr13:32357850
| BRCA2 | G2576* | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr16:68845654
- GRCh38:
- Chr16:68811751
| CDH1 | I300M | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr17:41244072
- GRCh38:
- Chr17:43092055
| BRCA1, LOC126862571 | I1112fs, I1159fs, I1031fs, I1032fs, I1089fs, I1091fs, I1111fs, I1133fs, I1156fs, I991fs, I1048fs, I1070fs, I1117fs, I1158fs, I863fs, I1047fs, I1071fs, I1088fs, I1092fs, I1118fs, I1132fs, I291fs | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr13:32910401
- GRCh38:
- Chr13:32336264
| BRCA2 | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr13:32936820
- GRCh38:
- Chr13:32362683
| BRCA2 | L2656V | Hereditary cancer-predisposing syndrome | Uncertain significance (May 29, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr13:32913826
- GRCh38:
- Chr13:32339689
| BRCA2 | N1778K | Hereditary cancer-predisposing syndrome | Likely benign (Mar 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:29099505
- GRCh38:
- Chr22:28703517
| CHEK2 | I232N, I299N, I342N, I78N | Hereditary cancer-predisposing syndrome, Familial cancer of breast | Uncertain significance (Sep 6, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:32914084-32914085
- GRCh38:
- Chr13:32339947-32339948
| BRCA2 | I1865fs | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr13:32912513
- GRCh38:
- Chr13:32338376
| BRCA2 | S1341P | Hereditary cancer-predisposing syndrome | Likely benign (Mar 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr13:32953526
- GRCh38:
- Chr13:32379389
| BRCA2 | Q2943fs | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:6029428-6029671
- GRCh38:
- Chr7:5989797-5990040
| PMS2 | | Malignant tumor of breast | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr13:32906725
- GRCh38:
- Chr13:32332588
| BRCA2 | | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr13:32912415
- GRCh38:
- Chr13:32338278
| BRCA2 | E1308A | Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Mar 23, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:133209358
- GRCh38:
- Chr12:132632772
| POLE | C2010R | Colorectal cancer, susceptibility to, 12 | Uncertain significance (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:48026399
- GRCh38:
- Chr2:47799260
| MSH6 | C124Y, C296Y, C426Y | Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:48010362
- GRCh38:
- Chr2:47783223
| MSH6 | | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr2:47703647
- GRCh38:
- Chr2:47476508
| MSH2 | D650G, D716G | Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Aug 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:108153618
- GRCh38:
- Chr11:108282891
| ATM | | Ataxia-telangiectasia syndrome | Likely benign (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:41246839
- GRCh38:
- Chr17:43094822
| BRCA1 | E190*, E237*, E126*, E148*, E149*, E192*, E234*, E236*, E69*, E125*, E166*, E169*, E211*, E109*, E170*, E189*, E210*, E110*, E167*, E195*, E196* | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr13:32929298
- GRCh38:
- Chr13:32355161
| BRCA2 | | Hereditary breast ovarian cancer syndrome | Likely benign (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7577550
- GRCh38:
- Chr17:7674232
| TP53 | G112fs, G205fs, G244fs, G85fs | Li-Fraumeni syndrome | Pathogenic (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:215595244
- GRCh38:
- Chr2:214730520
| BARD1 | | not provided, Familial cancer of breast | Conflicting interpretations of pathogenicity (Aug 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:23640536
- GRCh38:
- Chr16:23629215
| PALB2 | S859fs | Familial cancer of breast, Hereditary cancer-predisposing syndrome | Pathogenic (Dec 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:41243985
- GRCh38:
- Chr17:43091968
| BRCA1, LOC126862571 | R1141M, R1188M, R1076M, R1099M, R1100M, R1020M, R1061M, R1077M, R1147M, R1162M, R1187M, R892M, R1060M, R1121M, R1140M, R1146M, R1185M, R1117M, R1118M, R1120M, R1161M, R320M | Hereditary cancer-predisposing syndrome | Likely benign (Mar 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:33433399
- GRCh38:
- Chr17:35106380
| RAD51L3-RFFL, RAD51D | | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr17:59924476
- GRCh38:
- Chr17:61847115
| BRIP1 | F205V | Fanconi anemia complementation group J, Familial cancer of breast | Uncertain significance (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:215674183
- GRCh38:
- Chr2:214809459
| BARD1 | S37R | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr2:47703665
- GRCh38:
- Chr2:47476526
| MSH2 | V656A, V722A | Hereditary cancer-predisposing syndrome | Uncertain significance (Jun 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:68867191-68867403
- GRCh38:
- Chr16:68833288-68833500
| CDH1 | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr17:41215889-41221043
- GRCh38:
- Chr17:43063872-43069026
| BRCA1 | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:48018247
- GRCh38:
- Chr2:47791108
| MSH6 | | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr22:29091166
- GRCh38:
- Chr22:28695178
| CHEK2 | S221fs, S375fs, S413fs, S442fs, S485fs | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr22:29105992-29106157
- GRCh38:
- Chr22:28710004-28710169
| CHEK2 | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:215617169-215617280
- GRCh38:
- Chr2:214752445-214752556
| BARD1 | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:215661825
- GRCh38:
- Chr2:214797101
| BARD1 | E59Q | Familial cancer of breast, Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:32890629
- GRCh38:
- Chr13:32316492
| BRCA2 | F11C | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr12:133254279
- GRCh38:
- Chr12:132677693
| POLE | T202I | Colorectal cancer, susceptibility to, 12 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:41276047-41276048
- GRCh38:
- Chr17:43124030-43124031
| BRCA1 | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr17:41244899
- GRCh38:
- Chr17:43092882
| BRCA1 | | Hereditary breast ovarian cancer syndrome | Likely benign (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:6017254
- GRCh38:
- Chr7:5977623
| PMS2 | K493*, K613*, K617*, K669*, K680*, K698*, K701*, K752*, K804*, K815* | Malignant tumor of breast | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:37056017
- GRCh38:
- Chr3:37014526
| MLH1 | F160L, F17L, F225L, F258L | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr13:32928995-32929795
- GRCh38:
- Chr13:32354858-32355658
| BRCA2 | | Malignant tumor of breast | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr17:41209066-41209271
- GRCh38:
- Chr17:43057049-43057254
| BRCA1 | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr16:23632765
- GRCh38:
- Chr16:23621444
| PALB2 | E1011K | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr9:97879681
- GRCh38:
- Chr9:95117399
| FANCC, AOPEP | | not provided | Likely benign (Nov 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:32906915
- GRCh38:
- Chr13:32332778
| BRCA2 | K434Q | Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Mar 23, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:32950842
- GRCh38:
- Chr13:32376705
| BRCA2 | L2890V | Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome, not provided
| Uncertain significance (Jun 12, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:108151720-108152756
- GRCh38:
- Chr11:108280993-108282029
| ATM | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr17:41209066-41209988
- GRCh38:
- Chr17:43057049-43057971
| BRCA1 | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr17:41245183
- GRCh38:
- Chr17:43093166
| BRCA1 | S742fs, S789fs, S678fs, S700fs, S722fs, S741fs, S748fs, S762fs, S786fs, S788fs, S719fs, S747fs, S763fs, S493fs, S621fs, S661fs, S662fs, S677fs, S701fs, S718fs, S721fs | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:47703564-47703565
- GRCh38:
- Chr2:47476425-47476426
| MSH2 | | Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:41245687-41245700
- GRCh38:
- Chr17:43093670-43093683
| BRCA1 | T570fs, T617fs, T321fs, T449fs, T575fs, T614fs, T489fs, T528fs, T529fs, T547fs, T569fs, T591fs, T546fs, T549fs, T616fs, T490fs, T505fs, T506fs, T550fs, T576fs, T590fs | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr7:6026611
- GRCh38:
- Chr7:5986980
| PMS2 | | Hereditary cancer-predisposing syndrome | Likely benign (Jan 7, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr5:112090586-112092546
- GRCh38:
- Chr5:112754889-112756849
| APC | | Malignant tumor of breast, Carcinoma of colon | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:47641451
- GRCh38:
- Chr2:47414312
| MSH2 | L213P, L279P | Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:29085185-29085189
- GRCh38:
- Chr22:28689197-28689201
| CHEK2 | R272fs, R426fs, R464fs, R493fs, R536fs | Malignant tumor of breast | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr9:97873933
- GRCh38:
- Chr9:95111651
| AOPEP, FANCC | | Fanconi anemia | Likely benign (Jul 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:41246697
- GRCh38:
- Chr17:43094680
| BRCA1 | Q237fs, Q284fs, Q116fs, Q172fs, Q242fs, Q257fs, Q281fs, Q283fs, Q156fs, Q195fs, Q214fs, Q236fs, Q243fs, Q157fs, Q213fs, Q216fs, Q217fs, Q173fs, Q196fs, Q258fs | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:215593398-215595734
- GRCh38:
- Chr2:214728674-214731010
| BARD1 | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr16:68849534
- GRCh38:
- Chr16:68815631
| CDH1 | | Malignant tumor of breast | Likely benign | no assertion criteria provided |
| - GRCh37:
- Chr2:215595242-215595244
- GRCh38:
- Chr2:214730518-214730520
| BARD1 | | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr13:32913256
- GRCh38:
- Chr13:32339119
| BRCA2 | | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr2:48026874
- GRCh38:
- Chr2:47799735
| MSH6 | | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr9:98009711-98009963
- GRCh38:
- Chr9:95247429-95247681
| FANCC | | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr17:41243913
- GRCh38:
- Chr17:43091896
| BRCA1, LOC126862571 | S1165L, S1212L, S1085L, S1100L, S1141L, S1142L, S1144L, S1084L, S1101L, S1170L, S1124L, S1171L, S1211L, S344L, S1044L, S1123L, S1145L, S1164L, S1185L, S1186L, S1209L, S916L | Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Mar 23, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:41209067-41209153
- GRCh38:
- Chr17:43057050-43057136
| BRCA1 | | Carcinoma of colon, Malignant tumor of breast, Breast-ovarian cancer, familial, susceptibility to, 1
| Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr17:41246647
- GRCh38:
- Chr17:43094630
| BRCA1 | K254Q, K301Q, K173Q, K190Q, K233Q, K259Q, K274Q, K5Q, K133Q, K213Q, K300Q, K174Q, K189Q, K230Q, K253Q, K260Q, K275Q, K212Q, K231Q, K234Q, K298Q | Hereditary cancer-predisposing syndrome | Likely benign (Mar 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:41276030-41276112
- GRCh38:
- Chr17:43124013-43124095
| BRCA1 | | Breast-ovarian cancer, familial, susceptibility to, 1, Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr13:32911611
- GRCh38:
- Chr13:32337474
| BRCA2 | T1040fs | Malignant tumor of breast | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr11:108154961
- GRCh38:
- Chr11:108284234
| ATM | Y1252H | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr8:90990562
- GRCh38:
- Chr8:89978334
| NBN | | Microcephaly, normal intelligence and immunodeficiency | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47707892
- GRCh38:
- Chr2:47480753
| MSH2 | H773P, H839P | Malignant tumor of breast | Uncertain significance | no assertion criteria provided |